<?xml version="1.0" encoding="UTF-8"?>
<p id="par0010">There are currently no proven treatment for Coronavirus disease 2019 (Covid-19). There is no effective antiviral drug in the treatment of Covid-19 disease. It is an urgent need to seek an alternative strategy, especially in the treatment of serious patients. Convalescent Plasma (CP) therapy can be used for this disease. CP is the administration of antibodies collected from recently infected and recovered Covid-19 patients to Covid-19 patients for therapeutic purposes. CP was used during the 1918 flu epidemic and reduced mortality among plasma recipients [
 <xref rid="bib0015" ref-type="bibr">3</xref>]. CP treatment is a reliable treatment option for the prevention and treatment of infectious diseases for more than a hundred years [
 <xref rid="bib0020" ref-type="bibr">4</xref>]. However, the benefit of CP treatment to mortality in Ebola virus disease has not been showed [
 <xref rid="bib0025" ref-type="bibr">5</xref>]. Recently, CP was used as a effective and reliable treatment option in SARS-CoV-1 and Middle East respiratory syndrome (MERS) epidemics [
 <xref rid="bib0030" ref-type="bibr">6</xref>]. Therefore, it suggested that the use of CP transfusion may be beneficial in patients infected with SARS-CoV-2.
</p>
